FFH:TSXFairfax Financial Holdings Limited Analysis
Data as of 2026-06-07 - not real-time
CA$2,220.71
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Fairfax Financial (FFH) trades around CAD 2,220, nearly double its discounted cash‑flow fair value of about CAD 1,192, indicating a significant premium. The stock’s trailing P/E of 7.9 is well below the industry average of 17, suggesting relative cheapness on earnings, while the forward P/E of 10 remains modest. Margins are solid (gross ~43%, operating ~14%) and free cash flow exceeds CAD 2.4 bn, supporting the recently declared preferred dividend of $0.315 per share and a low payout ratio of roughly 7%. Technically, the price sits below the 20‑, 50‑ and 200‑day SMAs, the 30‑day volatility is high at 32%, but the beta is only 0.16, indicating limited market‑beta exposure.
The company announced a senior notes offering of US$750 m and a preferred dividend, underscoring confidence in its balance‑sheet strength despite a 7.8% revenue decline. With a modest debt‑to‑equity of 45.8% and a strong ROE of 17%, the fundamentals are resilient, yet the current market premium and bearish trend signal caution. Overall, FFH appears financially sound but may be priced for optimism, warranting a measured stance.
The company announced a senior notes offering of US$750 m and a preferred dividend, underscoring confidence in its balance‑sheet strength despite a 7.8% revenue decline. With a modest debt‑to‑equity of 45.8% and a strong ROE of 17%, the fundamentals are resilient, yet the current market premium and bearish trend signal caution. Overall, FFH appears financially sound but may be priced for optimism, warranting a measured stance.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 6/10
Key Factors
- Price well above DCF fair value
- Bearish technical positioning (below SMAs, support near 2,066)
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 7/10
Key Factors
- Attractive earnings multiple versus peers
- Strong cash generation and low payout ratio
- Increasing volume indicating renewed investor interest
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Solid ROE and operating margins
- Sustainable dividend supported by free cash flow
- Diversified global insurance and investment platform
Key Metrics & Analysis
Financial Health
Revenue Growth-7.80%
Profit Margin11.72%
P/E Ratio7.9
ROE17.22%
ROA4.34%
Debt/Equity45.82
P/B Ratio1.3
Op. Cash FlowCA$1.5B
Free Cash FlowCA$2.4B
Industry P/E17.0
Technical Analysis
TrendBearish
RSI49.2
SupportCA$2,066.16
ResistanceCA$2,286.85
MA 20CA$2,202.92
MA 50CA$2,297.90
MA 200CA$2,361.41
MACDBullish
VolumeIncreasing
Fear & Greed Index83.02
Valuation
Fair ValueCA$1,191.93
Target PriceCA$2,783.58
Upside/Downside25.35%
GradeOvervalued
TypeValue
Dividend Yield0.94%
Risk Assessment
Beta0.16
Volatility32.17%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.